Genmab A/S Net Foreign Exchange Loss
Genmab A/S (GNMSF) reported Net Foreign Exchange Loss of $77.00 million for the 3-month period ending 2025-06-30, per its 6-K filed 2025-08-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2025-08-07
- Genmab A/S net foreign exchange loss for the quarter ending 2024-06-30 was 256.00M DKK, a 2460.00% increase year-over-year.
- Genmab A/S net foreign exchange loss for the quarter ending 2023-06-30 was 10.00M DKK.
DKK
| Period end | Net Foreign Exchange Loss 3 month | Net Foreign Exchange Loss 6 month | Net Foreign Exchange Loss 12 month | Net Foreign Exchange Loss 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | 1.59B DKK 6-K · filed 2025-02-12 | |||
| 2024-06-30 | 256.00M DKK 6-K · filed 2024-08-08 | 316.00M DKK 6-K · filed 2024-08-08 | ||
| 2023-12-31 | 1.28B DKK 6-K · filed 2025-02-12 | 889.00M DKK 6-K · filed 2024-02-14 | ||
| 2023-06-30 | 10.00M DKK 6-K · filed 2024-08-08 | 439.00M DKK 6-K · filed 2024-08-08 | ||
| 2022-12-31 | 1.66B DKK 6-K · filed 2025-02-12 | |||
| 2021-12-31 | 1.47B DKK 6-K · filed 2022-02-16 | |||
| 2020-12-31 | 1.46B DKK 6-K · filed 2023-02-22 | |||
| 2017-12-31 | 330.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Net Foreign Exchange Loss 3 month | Net Foreign Exchange Loss 6 month |
|---|---|---|
| 2025-06-30 | $77.00M 6-K · filed 2025-08-07 | $108.00M 6-K · filed 2025-08-07 |
| 2024-06-30 | $17.00M 6-K · filed 2025-08-07 | $24.00M 6-K · filed 2025-08-07 |